Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
HH Hansen, S Pors, MW Andersen, M Vyberg… - Scientific Reports, 2023 - nature.com
Non-alcoholic steatohepatitis (NASH) is emerging as a major cause of hepatocellular
carcinoma (HCC), however, it is not resolved if compounds in late-stage clinical …
carcinoma (HCC), however, it is not resolved if compounds in late-stage clinical …
[HTML][HTML] Immunotherapy and MASLD-Related HCC: Should We Reconsider the Role of Etiology in the Therapeutic Approach to HCC?
G Vizioli, A Nicoletti, D Feliciani, B Funaro… - Applied Sciences, 2025 - mdpi.com
Hepatocellular carcinoma (HCC) accounts for 90% of primary liver cancers and typically
arises in the context of chronic liver disease. With the increasing prevalence of metabolic …
arises in the context of chronic liver disease. With the increasing prevalence of metabolic …
Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkage
JE Kim, HS Kim, W Kim, EH Lee, S Kim, T Kim… - … and Targeted Therapy, 2025 - nature.com
Dynamic communication between hepatocytes and the environment is critical in
hepatocellular carcinoma (HCC) development. Clinical immunotherapy against HCC is …
hepatocellular carcinoma (HCC) development. Clinical immunotherapy against HCC is …